Short Antiretroviral Therapy Beneficial during Primary HIV Infection

A short course of combination antiretroviral therapy (ART) started during primary HIV infection is associated with CD4 T-cell gains and viral load reductions after treatment is stopped, according to a meta-analysis published in the December 6 edition of PLoS ONE.


Most U.S. Providers Support PrEP, but Not Many Have Prescribed It

About three-quarters of infectious disease physicians in North America said they favored HIV pre-exposure prophylaxis (PrEP), but only 9% reported that they had prescribed Truvada (tenofovir/emtricitabine) for this purpose, according to a report in the December 6, 2013, advance edition of Clinical Infectious Diseases.


Top 13 HIV and Hepatitis Stories of 2013

In our last issue for 2013, reviews some the year's major HIV, viral hepatitis, and related news highlights, including the advent of effective new therapies for hepatitis C, new global guidelines recommending earlier HIV treatment, and mixed results in the HIV cure field.


Happy New Year from


Happy Holidays from

alt Complete 2013 Conference Coverage 2013 conference and meeting coverage.

Full conference listing





HIV Infection Linked to Structural Heart Disease

People with HIV who have detectable viral load are more likely to have structural heart problems such as left ventricular hypertrophy, diastolic dysfunction, or pulmonary hypertension, according to research presented at the recent EuroEcho-Imaging 2013 conference in Istanbul.